Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

FDMT Stock Annual Cash Flow. Download in Excel

4D Molecular Therapeutics Inc logo

4D Molecular Therapeutics Inc

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

7.99
 
USD
  
-0.42
  
(-4.99%)
Previous close: 8.41  Open: 8.41  Bid: 7.8  Ask: 8.23
52 week range    
7.32   
   36.25
Mkt Cap: 401 M  Avg Vol (90 Days): 847,275
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 22nd November 2024

Stock Rankings

47
MarketXLS Rank
60
Value
38
Technical
44
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

FDMT Cash Flow

Annual
Invalid dateDec-20Dec-21Dec-22Dec-23
(Increase) Decrease in other current liabilities366000.0-15 M-3 M-558000.0
(Increase) Decrease in other working capital75000.0-11000.0-70000.0
(Increase) Decrease in payables43000.02 M-2 M896000.0
(Increase) Decrease in receivables-508000.01 M47000.0
CapitalExpenditureReported1000000.09 M12 M3 M
Cash at beginning of period50 M277 M153 M52 M
Cash at end of period277 M153 M52 M52 M
Cash flow-51 M-69 M-87 M-76 M
CashFlowFromContinuingInvestingActivities-1000000.0-173 M-17 M116 M
ChangeInAccountPayable43000.02 M-2 M896000.0
ChangeInAccruedExpense2 M689000.02 M3 M
ChangeInPayablesAndAccruedExpense2 M3 M847000.04 M
ChangeInPrepaidAssets-3 M-4 M1 M-1 M
ChangeInWorkingCapital-691000.0-14 M-1 M2 M
ChangesInAccountReceivables-508000.01 M47000.0
CommonStockPayments-468000.0
Depreciation1 M2 M2 M4 M
Depreciation unreconciled1 M4 M5 M5 M
DepreciationAndAmortization1 M3 M4 M6 M
FinancingCashFlow279 M118 M3 M157 M
Free cash flow-52 M-78 M-98 M-79 M
GainLossOnSaleOfPPE-1000.0
Issuance of capital stock207 M118 M3 M7 M
IssuanceOfCapitalStock207 M118 M3 M7 M
Net cash from financing activities279 M118 M3 M8 M
Net cash from investing activities-1000000.0-173 M-17 M116 M
Net cash from operating activities-51 M-69 M-87 M-76 M
Net change in cash & cash equivalents227 M-124 M-101 M197 M
Net income from continuing operations-57 M-71 M-107 M-101 M
NetCommonStockIssuance207 M118 M2 M7 M
NetInvestmentPropertiesPurchaseAndSale-164 M-6 M118 M
NetInvestmentPurchaseAndSale-164 M-6 M118 M
NetPPEPurchaseAndSale-1000000.0-9 M-12 M-3 M
NetPreferredStockIssuance72 M
Operating (gains) losses-1000.0
Other financing charges net823000.01 M
Other non-cash items5 M13 M17 M18 M
PreferredStockIssuance72 M
ProceedsFromStockOptionExercised857000.0433000.0
Purchase of Float term investments-169 M-153 M-55 M
Purchase of property plant & equipment-1000000.0-9 M-12 M-3 M
PurchaseOfInvestment-169 M-153 M-55 M
PurchaseOfPPE-1000000.0-9 M-12 M-3 M
Repurchase of capital stock-468000.0
Revenue per share2 M3 M301000.0
Sale of short term investments5 M148 M173 M
SaleOfInvestment5 M148 M173 M
StockBasedCompensation5 M14 M17 M20 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University